申请人:Shionogi & Co., Ltd.
公开号:US06703385B1
公开(公告)日:2004-03-09
The present invention provides a compound having sPLA2 inhibiting activity.
The compound represented by the formula (I):
wherein R1 is (a) C1 to C20 alkyl, C2 to C20 alkenyl, C2 to C20 alkynyl, carbocyclic groups, heterocyclic groups or the like; R2 is COCONH2 or the like; Q1 is a nitrogen atom or C—R4; one of R3 and R4 is —(L2)-(acidic group) wherein L2 is a group connecting with an acid group and the length of the connecting groups 1 to 5 atoms, and the other is a hydrogen atom; R21 and R22 are hydrogen atoms or the like; X is —CR23R24— or the like wherein R23 and R24 are hydrogen atoms or the like; Y is —CR25R26— or the like wherein R25 and R26 are hydrogen atoms or the like; Z is CH2 or the like; a broken line ( - - - ) represents the presence or absence of a bond,
its prodrug, their pharmaceutically acceptable salt, or solvate thereof.
本发明提供一种具有sPLA2抑制活性的化合物。该化合物由式(I)表示:其中R1为C1到C20烷基,C2到C20烯基,C2到C20炔基,碳环族,杂环族或类似物;R2为COCONH2或类似物;Q1为氮原子或C—R4;R3和R4中的一个为—(L2)-(酸性基团),其中L2为与酸基团连接的基团,连接基团的长度为1到5个原子,另一个为氢原子;R21和R22为氢原子或类似物;X为—CR23R24—或类似物,其中R23和R24为氢原子或类似物;Y为—CR25R26—或类似物,其中R25和R26为氢原子或类似物;Z为CH2或类似物;破折号(- - -)表示键的存在或缺失,其前体,它们的药学上可接受的盐,或其溶剂化合物。